Vystar Invited to Present Revolutionary Product at International Latex and Synthetic Polymer Dispersions Conference

Rapra Technology Limited has invited Vystar Corporation to present its revolutionary Vytex(TM) NRL product at the Latex and Synthetic Polymer Dispersions Conference 2008 in Madrid in January.

"Vytex(TM) Natural Rubber Latex: A Proposed Industry Standard for the Manufacture of Commercial Natural Rubber Products" will be presented by Vystar President and Chief Operating Officer William R. Doyle.

"Vytex NRL was designed to offer a standardized source material for the production of natural rubber products," Doyle said. "We have repeatedly completed large-scale pilot production runs producing Vytex NRL that consistently meet the strictest industry standards for 'safe' NRL while retaining all the positive properties of NRL: barrier protection, elasticity, durability, stability and 'softness' for a wide range of applications. We're very excited about the opportunity to talk about Vytex NRL as the new standardized NRL source material in Madrid."

Vytex NRL is natural rubber latex that has undergone a proprietary process removing the antigenic proteins that trigger allergic reactions. Commercially available and appropriate for a wide array of applications, Vytex NRL can be integrated into many existing manufacturing environments without investment in additional equipment. In addition, when compared to traditional NRL or synthetic products, its chemical and physical properties demonstrate similar or superior performance characteristics. Vytex NRL is only slightly more expensive than traditional NRL and is competitive with many "natural rubber free" alternative materials.

The first sample batches of Vytex NRL will be shipped to the laboratories of manufacturers in industries ranging from adhesives, foams, and balloons to medical gloves, condoms and threads in fourth quarter 2007. Over the two years since Vystar first introduced Vytex NRL to Rapra 2006 conference attendees, Vytex NRL has moved into test production, been used in small runs of medical gloves, condoms and balloons, and attained consistent test scores that are backed up by quality assurance methodologies to ensure ongoing repeatability.

Vytex NRL development continues under the close scrutiny of the Vytex Technical Advisory Board of health care experts as well as that of the company's board of directors. Early in 2007, Vytex NRL earned Vystar Corporation a berth as a Top Ten Innovative Technology Company in Georgia.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smithers Rapra Technology Ltd. (2019, February 10). Vystar Invited to Present Revolutionary Product at International Latex and Synthetic Polymer Dispersions Conference. AZoM. Retrieved on April 23, 2024 from https://www.azom.com/news.aspx?newsID=10108.

  • MLA

    Smithers Rapra Technology Ltd. "Vystar Invited to Present Revolutionary Product at International Latex and Synthetic Polymer Dispersions Conference". AZoM. 23 April 2024. <https://www.azom.com/news.aspx?newsID=10108>.

  • Chicago

    Smithers Rapra Technology Ltd. "Vystar Invited to Present Revolutionary Product at International Latex and Synthetic Polymer Dispersions Conference". AZoM. https://www.azom.com/news.aspx?newsID=10108. (accessed April 23, 2024).

  • Harvard

    Smithers Rapra Technology Ltd. 2019. Vystar Invited to Present Revolutionary Product at International Latex and Synthetic Polymer Dispersions Conference. AZoM, viewed 23 April 2024, https://www.azom.com/news.aspx?newsID=10108.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.